Teva Pharmaceutical Industries Ltd. (TEVA)
40.39
+0.44
(+1.10%)
USD |
NYSE |
Oct 27, 16:00
40.40
+0.02
(+0.04%)
After-Hours: 20:00
Teva Pharmaceutical Industries Market Cap : 47.05B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 47.05B |
| October 26, 2026 | 46.54B |
| October 23, 2026 | 45.91B |
| October 22, 2026 | 46.84B |
| October 21, 2026 | 47.32B |
| October 20, 2026 | 47.59B |
| October 19, 2026 | 48.13B |
| October 16, 2026 | 48.35B |
| October 15, 2026 | 47.89B |
| October 14, 2026 | 47.44B |
| October 13, 2026 | 48.06B |
| October 12, 2026 | 47.96B |
| October 09, 2026 | 47.88B |
| October 08, 2026 | 45.73B |
| October 07, 2026 | 45.64B |
| October 06, 2026 | 45.59B |
| October 05, 2026 | 46.20B |
| October 02, 2026 | 46.05B |
| October 01, 2026 | 45.80B |
| September 30, 2026 | 46.13B |
| September 29, 2026 | 46.38B |
| September 28, 2026 | 45.30B |
| September 25, 2026 | 45.66B |
| September 24, 2026 | 46.86B |
| September 23, 2026 | 45.45B |
| Date | Value |
|---|---|
| September 22, 2026 | 46.04B |
| September 21, 2026 | 46.67B |
| September 18, 2026 | 45.41B |
| September 17, 2026 | 45.66B |
| September 16, 2026 | 44.89B |
| September 15, 2026 | 45.73B |
| September 14, 2026 | 45.11B |
| September 11, 2026 | 43.10B |
| September 10, 2026 | 42.35B |
| September 09, 2026 | 42.93B |
| September 08, 2026 | 42.83B |
| September 04, 2026 | 42.36B |
| September 03, 2026 | 42.66B |
| September 02, 2026 | 43.68B |
| September 01, 2026 | 42.16B |
| August 31, 2026 | 42.00B |
| August 28, 2026 | 42.45B |
| August 27, 2026 | 43.83B |
| August 26, 2026 | 44.18B |
| August 25, 2026 | 44.39B |
| August 24, 2026 | 43.02B |
| August 21, 2026 | 43.50B |
| August 20, 2026 | 42.88B |
| August 19, 2026 | 43.65B |
| August 18, 2026 | 42.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 125.75B |
| Merck & Co., Inc. | 350.10B |
| RedHill Biopharma Ltd. | 2.725M |
| AstraZeneca PLC | 527.53B |
| Eli Lilly & Co. | 1.207T |
Market Cap Related Metrics
| PE Ratio | 67.92 |
| PS Ratio | 2.709 |
| Price to Book Value | 6.069 |
| Price to Free Cash Flow | 32.19 |
| Price | 40.39 |
| Earnings Yield | 1.47% |
| Operating PE Ratio | 14.42 |
| Normalized PE Ratio | 25.45 |